METAHEPS
MetaHeps GmbH provides consulting and solutions for drug-induced liver injury (DILI) in clinical drug-development and postmarketing. It is a unique service provider that generates a personalized cell model reflecting individual drug hepatotoxicity from a small patient blood sample. Customers are research driven pharmaceutical companies and global acting CROs, using Metaheps’ services in clinical phases of drug development as well as postmarketing to diagnose or exclude Druginduced liver injury (DILI) in individual patients. MetaHeps vision is to increase access of patients to novel drugs by addressing DILI issues in drug development in an unrivaled and innovative approach.
METAHEPS
Social Links:
Industry:
Biotechnology Consulting Health Care
Founded:
2014-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.metaheps.com
Total Employee:
1+
Status:
Active
Contact:
+49089440073130
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SSL By Default Apache IPv6 Apache 2.4 DigiCert SSL Pound Sterling Japanese Yen RapidSSL Unix Strato
Similar Organizations
Bioceros
Bioceros provides services related to the preclinical development of monoclonal antibodies and generation protein-producing cell lines.
Inpharmatis
Inpharmatis offers comprehensive regulatory affairs services to life Science industry including drug development & vigilance services.
PharmaFacts
PharmaFacts provides consultation services for preclinical drug development program.
Investors List
Innovative Medicines Initiative
Innovative Medicines Initiative investment in Grant - MetaHeps
European Commission
European Commission investment in Grant - MetaHeps
Bavarian Ministry of Economic Affairs, Energy and Technology
Bavarian Ministry of Economic Affairs, Energy and Technology investment in Grant - MetaHeps
EIT Health
EIT Health investment in Grant - MetaHeps
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - MetaHeps
